( NASDAQ-SMALL:CTSO )

News from CytoSorbents Corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jan 08, 2018, 07:15 ET CytoSorbents Pre-Announces Preliminary Fourth Quarter and Full Year 2017 Results and Issues Stockholder Letter

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...


Jan 03, 2018, 07:05 ET CytoSorbents To Provide Corporate Update at Biotech Showcase 2018

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to treat deadly...


Dec 21, 2017, 14:58 ET CytoSorbents Achieves Key Milestone with FDA Approval of the U.S. REFRESH 2 Pivotal Cardiac Surgery Trial IDE Application

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to treat deadly...


Dec 19, 2017, 07:00 ET CytoSorbents Receives $676,739 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to treat deadly...


Dec 11, 2017, 08:10 ET German Federal Ministry of Education and Research to Fund the CytoSorb® Endocarditis REMOVE Trial

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using CytoSorb® blood purification to treat deadly...


Nov 29, 2017, 07:00 ET CytoSorbents to Present at the LD Micro Main Event Investor Conference

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using blood purification to prevent or treat life-threatening injury...


Nov 09, 2017, 16:17 ET CytoSorbents Continues Strong Trajectory of Growth in the Third Quarter 2017

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using blood purification to prevent or treat life-threatening injury...


Nov 09, 2017, 07:15 ET CytoSorbents Recognized on Deloitte's 2017 Technology Fast 500™ as One of the Fastest Growing Companies in North America

CytoSorbents Corporation (NASDAQ: CTSO) announced that at last evening's awards ceremony, it ranked 7th amongst 21 medical device companies, and...


Nov 02, 2017, 08:00 ET CytoSorbents to Report Q3 2017 Operating and Financial Results

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using blood purification to treat life-threatening injury and...


Nov 01, 2017, 07:05 ET CytoSorbents Awarded Approximately $1.0 Million in Phase II SBIR Funding to Optimize New Treatment Approaches for Severe Hyperkalemia

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using blood purification to treat life-threatening injury and...


Oct 19, 2017, 09:25 ET CytoSorb® Usage During Valve Replacement Surgery for Infective Endocarditis Helps Stabilize Patients and May Improve Survival

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using CytoSorb® blood purification to treat deadly inflammation in...


Oct 10, 2017, 07:15 ET CytoSorbents to Present at the 2017 BIO Investor Forum

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using CytoSorb® blood purification to treat deadly inflammation in...


Sep 26, 2017, 07:05 ET CytoSorbents Introduces the CytoSorb Therapeutic ECMO™ Kit at the 2017 European Society of Intensive Care Medicine Congress

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using CytoSorb® blood purification to treat deadly inflammation in...


Sep 25, 2017, 07:15 ET Key Clinical Study Showing Reversal of Refractory Septic Shock in Patients Treated with CytoSorb®

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using CytoSorb® blood purification to treat deadly inflammation in...


Sep 14, 2017, 08:15 ET World Sepsis Day 2017: CytoSorbents Sponsors the Sepsis Update 2017 Congress and Sepsis Heroes Ceremony

CytoSorbents Corporation (NASDAQ: CTSO), a leader in critical care immunotherapy using its CytoSorb® blood purification technology to help patients...


Sep 11, 2017, 07:15 ET Aferetica and CytoSorbents Partner to Enhance the Success of Solid Organ Transplantation

Aferetica srl, an innovative start-up specializing in blood purification, and CytoSorbents Corporation (NASDAQ: CTSO), a critical care...


Sep 06, 2017, 07:00 ET CytoSorbents to Present at the 2017 Rodman & Renshaw Annual Global Investment Conference

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to prevent or...


Sep 05, 2017, 08:05 ET CytoSorbents Highlights Important Research Advances in Traumatic Brain Injury, Hemorrhagic Shock, and Severe Hyperkalemia at the Military Health System Research Symposium

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to prevent or...


Aug 14, 2017, 07:15 ET CytoSorbents Awarded $719,000 Grant To Acutely Stabilize Severe Burn Patients

CytoSorbents Corporation (NASDAQ: CTSO), a leader in critical care immunotherapy specializing in blood purification, announced that it has been...


Aug 07, 2017, 16:15 ET CytoSorbents Reports Record Quarterly Total Revenue and Product Sales in the Second Quarter 2017

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to...


Aug 01, 2017, 07:00 ET CytoSorbents to Report Q2 2017 Operating and Financial Results

CytoSorbents Corporation (CTSO), CytoSorbents Corporation (CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood...


Jul 17, 2017, 09:15 ET CytoSorbents Expands Distribution and Sales of CytoSorb® to treat Deadly Inflammation in Panama with DRGR

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using CytoSorb® blood purification to treat deadly inflammation in...


Jul 13, 2017, 07:05 ET CytoSorbents Awarded $1 Million STTR Phase II Contract To Advance Development of Life-Saving Universal Plasma

CytoSorbents Corporation (NASDAQ: CTSO), a leader in critical care immunotherapy specializing in blood purification, today announced that...


Jul 05, 2017, 07:05 ET CytoSorbents Receives Additional $5 Million in Non-Dilutive Debt Financing from Bridge Bank

CytoSorbents Corporation (NASDAQ: CTSO), a leader in critical care immunotherapy specializing in blood purification, announced that on June 30,...


Jun 15, 2017, 07:05 ET CytoSorbents Announces Director and Management Open Market Stock Purchases

CytoSorbents Corporation (CTSO), a critical care immunotherapy leader using CytoSorb® blood purification to treat deadly inflammation in...